The Ledger

Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.

clear all ✕

why aren't all 5 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable

Assertion Partly supported
Walaliade: AI models outperform human physicians in top 2017 medical journals
“Two years ago, there weren't that many examples of prominent journals publishing AI and healthcare pieces where it was, you know, shown to work in healthcare context, and now it feels like every month there's a new nature paper or something coming out where, y…”
Malinka Walaliyadde Jan 2, 2019 ▶ 1:52 a16z Podcast | Taking the Pulse on Bio
Assertion Partly supported
Walaliyadde: Assurex generated $60M in revenue despite only 20% test reimbursement
“There's a company called Assurex in mental health. They were making sixty million dollars in revenue last year, but they were only getting 20% of their tests reimbursed.”
Malinka Walaliyadde Jan 2, 2019 ▶ 24:40 a16z Podcast | On the Genomics of Disease, From Science to Business
Assertion Supported
Walaliade: Hospitals are increasingly taking financial risk for patient care
“Hospitals are increasingly taking financial risk on their patients. They are financially on the hook for excessive care.”
Malinka Walaliyadde Jan 2, 2019 ▶ 12:53 a16z Podcast | Taking the Pulse on Bio
Assertion Supported
Walaliyadde: One dominant company drove a decade of sequencing cost drops
“The dominant player in the sequencing machine space has almost entirely by itself been driving down the cost of sequencing over the last decade or so.”
Malinka Walaliyadde Jan 2, 2019 ▶ 4:15 a16z Podcast | On the Genomics of Disease, From Science to Business
Assertion Supported
Walaliyadde: Illumina expanded into the applications layer via Verinata, Grail, and Helix
“Lumina has started realizing that as well and is itself building applications. They bought a company called Verinata, which is a NIPT company... You know, they have a cancer company called Grail... There's a company called Helix. So they have started participa…”
Malinka Walaliyadde Jan 2, 2019 ▶ 21:42 a16z Podcast | On the Genomics of Disease, From Science to Business
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.